Ophthalmology Doctors in Quincy, MA Accepting Medicare

8 Ophthalmology doctors found. Showing 1 - 8

David G Lotufo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1900 Crown Colony Dr, Suite 301, Quincy, MA 02169 Phone: 617-472-5242    Fax: 617-471-5093

Helen Rego Moreira, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 300 Congress St, Suite 200, Quincy, MA 02169 Phone: 617-471-5665

Cindy W. Chao, M.D., PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1900 Crown Colony Dr Ste 301, Quincy, MA 02169 Phone: 617-770-4400    Fax: 617-471-5093

Dr. Helene Y Lam, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1250 Hancock St, Ophthalmology Dept, Quincy, MA 02169 Phone: 617-774-0780    Fax: 617-774-0795

Mr. Steven A Nielsen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 300 Congress St, Suite 201, Quincy, MA 02169 Phone: 617-471-5665    Fax: 617-471-7041

Gary E Borodic, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1261 Furnace Brook Pkwy, Suite 15, Quincy, MA 02169 Phone: 617-770-0011    Fax: 617-770-0030

Dr. Domenic M Strazzulla, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 500 Congress St, Suite 1a-1, Quincy, MA 02169 Phone: 617-770-1505    Fax: 617-479-6832

John M Carroll, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1900 Crown Colony Dr, Suite 301, Quincy, MA 02169 Phone: 617-472-5242    Fax: 617-770-2975

News Archive

Biologist has identified gene patterns that characterize a biologically distinct subtype of estrogen receptor negative breast tumor

University of North Carolina molecular biologist Charles Perou has identified the pattern of genes that characterize a biologically distinct subtype of estrogen receptor negative breast tumor.

Flavors attract both youth and adults to use e-cigarettes

As more and more youth use electronic cigarettes, combined with research showing the health consequences of vaping - including nicotine addiction - researchers at the University of North Carolina-Chapel Hill found that non-menthol flavors attract youth and adults to use e-cigarettes and that the use of flavored e-cigarettes contributes to multiple pathways linked to higher e-cigarette use among youth.

New device can produce blood-based diagnostic results in minutes

Samuel K. Sia, assistant professor of biomedical engineering at Columbia Engineering, has developed an innovative strategy for an integrated microfluidic-based diagnostic device-in effect, a lab-on-a-chip-that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.

Watson Laboratories sued by Teva Women's Health over generic Cenestin ANDA

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.

Studies show XIFAXAN 550 mg tablets demonstrate significant relief of global IBS symptoms

Salix Pharmaceuticals, Ltd. today announced the New England Journal of Medicine has published results from TARGET 1 and TARGET 2, the Company's two pivotal Phase 3 efficacy and safety studies of XIFAXAN (rifaximin) 550 mg tablets for the treatment of Irritable Bowel Syndrome without constipation, or Non-C IBS.

Read more Medical News

› Verified 4 days ago